Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v6-FR
Language French French
Date Updated 2022-02-10 2019-01-02
Drug Identification Number 00360414 00360414
Brand name CEENU CEENU
Common or Proper name Lomustine Lomustine
Company Name BRISTOL-MYERS SQUIBB CANADA BRISTOL-MYERS SQUIBB CANADA
Ingredients LOMUSTINE LOMUSTINE
Strength(s) 100MG 100MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 1 BTL x 20 1 BTL x 20
ATC code L01AD L01AD
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-08-30 2019-08-30
Actual discontinuation date 2019-09-30
Remaining supply date 2019-08-30 2019-08-30
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments